Home › NDC Lookup › RxCUI directory › RxCUI 2709438

Tizanidine 0.4 MG/ML Oral Solution [Ontralfy] — RxCUI 2709438

RxNorm drug concept · Semantic branded drug
RxCUI 2709438 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2709438
Official nameTizanidine 0.4 MG/ML Oral Solution [Ontralfy]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOntralfy 0.4 MG/ML Oral Solution; Ontralfy 2 MG in 5 mL Oral Solution; Ontralfy 2 MG per 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tizanidine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tizanidine is a muscle relaxant prescribed to manage spasticity — that's the uncomfortable muscle stiffness, tightness, or spasms that can come with conditions like multiple sclero...
  • Yes, it actually matters a lot — and it's different depending on whether you're taking a tablet or a capsule. Food increases how much drug your body absorbs from the tablet, but it...
  • Does it matter if I take tizanidine with food or without?
  • Very likely, yes — drowsiness is one of the most common side effects and can be significant, especially when you first start or when the dose is being adjusted. It can interfere wi...
📖 Read our full Tizanidine guide →

🕸️ Concept Web — How Tizanidine 0.4 MG/ML Oral Solution [Ontralfy] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tizanidine 0.4 MG/ML Oral Solution [Ontralfy] RxCUI 2709438

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tizanidine 57258
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ontralfy 2709433
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tizanidine Oral Solution 2709431
    • Tizanidine Oral Liquid Product 2709430
    • Tizanidine Oral Product 1162724
    • Tizanidine Oral Solution [Ontralfy] 2709437
    • Ontralfy Oral Liquid Product 2709436
    • Ontralfy Oral Product 2709435
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tizanidine 0.4 MG/ML Oral Solution SCD · 2709432
  • Tizanidine 0.4 MG/ML SCDC · 2709429
  • Tizanidine Oral Solution SCDF · 2709431
  • Tizanidine Oral Liquid Product SCDG · 2709430
  • Tizanidine Oral Product SCDG · 1162724

Brand-Name Concepts

  • Tizanidine 0.4 MG/ML [Ontralfy] SBDC · 2709434
  • Tizanidine Oral Solution [Ontralfy] SBDF · 2709437
  • Ontralfy Oral Liquid Product SBDG · 2709436
  • Ontralfy Oral Product SBDG · 2709435
  • Ontralfy BN · 2709433

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2709438 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69528-0310-16 473 mL in 1 BOTTLE, PLASTIC (69528-310-16) Ontralfy Rosemont Pharmaceuticals, LLC 2025-10-01
Observed labelers: Rosemont Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.